$ORRF Cashflow Statement | Understand Stock

$ORRF

$44.14 -$0.15 (0.34%) Close

$ORRF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Net (discount accretion) premium amortization
Depreciation and amortization expense
Impairment of intangibles
Provision for credit losses - loans
Recovery of credit losses - unfunded loan commitments
Share-based compensation
Gains on sales of loans originated for sale
Fair value adjustment on loans held for sale
Mortgage loans originated for sale
Proceeds from sales of loans originated for sale
Gains on sale of portfolio loans
Net gain on disposal of OREO and premises held for sale
Writedown of OREO and premises held for sale
Net loss on disposal of premises and equipment
Deferred income tax (benefit)
Investment securities (gains) losses
Provision for legal settlement
Payment of legal settlement
Return on investments in limited partnerships
Loss on derivative terminations
Net losses (gains) on derivatives
Income from life insurance
Premium on branch sale
Decrease (increase) in accrued interest receivable and other assets
(Decrease) increase in accrued interest payable and other liabilities
Other, net
Net cash provided by operating activities
Cash flows from investing activities
Proceeds from sales of AFS securities
Maturities, repayments and calls of AFS securities
Purchases of AFS securities
Net cash and cash equivalents received from acquisitions
Net purchases of restricted investments in bank stocks
Net distributions from investments in limited partnerships
Net (increase) decrease in loans
Proceeds from sales of portfolio loans
Investment in limited partnerships
Investment in limited partnerships, net
Purchases of bank premises and equipment
Proceeds from disposal of OREO and premises held for sale
Proceeds from disposal of bank premises and equipment
Net cash paid in branch sale
Purchases of bank owned life insurance
Death benefit proceeds from life insurance contracts
Other
Net cash (used in) provided by investing activities
Cash flows from financing activities
Net (decrease) increase in deposits
Net decrease (increase) in borrowings with original maturities less than 90 days
Proceeds from other short-term borrowings
Payments on other short-term borrowings
Proceeds from FHLB advances with original maturities greater than 90 days
Payments on FHLB advances with original maturities greater than 90 days
Settlement of terminated derivatives
Payment of subordinated notes issuance costs
Payments on subordinated notes
Dividends paid
Acquisition of treasury stock
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting
Proceeds from issuance of employee stock purchase plan shares
Other
Net cash provided by financing activities

Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental disclosure of cash flow information:
Interest
Income taxes
Supplemental schedule of noncash investing and financing activities:
Loans transferred from LHFS to portfolio loans
OREO acquired in settlement of loans
Premises and equipment transferred to held for sale
Lease liabilities arising from obtaining ROU assets
Deposits held for assumption in connection with sale of bank branch
Noncash transactions related to merger:
Assets acquired
Liabilities assumed

Comments